Profile
APDN DHR-PB TMO DHR IDXX A
Company Name Applied DNA Sciences, Inc. Danaher Corporation Thermo Fisher Scientific Inc. Danaher Corporation IDEXX Laboratories, Inc. Agilent Technologies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research
Market Cap $2.92M $916.76B $210.04B $154.09B $57.77B $40.65B
Employees 0.05K 79.00K 125.00K 61.00K 11.00K 17.90K
CEO James A. Hayward Sc.D. Rainer M. Blair Marc N. Casper Rainer M. Blair Jonathan J. Mazelsky Padraig McDonnell
Ratings
APDN DHR-PB TMO DHR IDXX A
Quant Rating Score 2 5 3 3 3 3
Quant Rating Sell Strong Buy Neutral Neutral Neutral Neutral
Trading
APDN DHR-PB TMO DHR IDXX A
Last Close $5.62 $1261.26 $565.24 $213.83 $722.12 $146.08
High 52 $6 $1261.26 $606.74 $250.59 $722.94 $152.6
Low 52 $0.05 $1261.26 $390.2 $174.64 $361.04 $99.29
Price vs. 52 Week High -6.33 % 0 % -6.84 % -14.67 % -0.11 % -4.27 %
Price vs. 52 Week Low 11140 % 0 % 44.86 % 22.44 % 100.01 % 47.12 %
Total Return
APDN DHR-PB TMO DHR IDXX A
1 Month Return 31.62 % 0 % 4.03 % -0.54 % 14.41 % 3.13 %
3 Month Return 23.52 % 0 % 21.07 % 7.33 % 12.49 % 27.15 %
6 Month Return 542.29 % 0 % 33.75 % 8.32 % 51.99 % 34.8 %
9 Month Return 3182.71 % 0 % -2.94 % 0.8 % 54.12 % -1.29 %
YTD Return 2654.9 % 0 % 8.65 % -6.85 % 74.66 % 8.74 %
1 Year Return 2915.02 % 0 % 0.79 % -14.49 % 73.59 % 4.04 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
APDN DHR-PB TMO DHR IDXX A
Dividend Yield Percentage (TTM) - 0.57 % 0.3 % 0.57 % - 0.69 %
Dividend Paid and Capex Coverage Ration (TTM) -0.32 % 2.94 % 3.54 % 2.94 % 8.09 % 4.01 %
Dividend Per Share (TTM) - 1.23 % 1.68 % 1.23 % - 0.99 %
Payout Ratio (TTM) -105.06 % 24.18 % 9.48 % 24.18 % - 22.95 %
Growth
APDN DHR-PB TMO DHR IDXX A
Asset Growth -6.32 % -8.22 % 1.03 %
Gross Profit Growth -81.62 % 1.23 % 8.63 %
Revenue Growth -74.33 % -0.06 % 6.46 %
Revenue 3 Year -96.69 % -20.76 % 25.23 %
Revenue 5 Year -99.26 % 30.38 % 69.09 %
Revenue 10 Year -99.46 % 15.17 % 218.38 %
EBIT Growth -28.04 % -7.67 % 3.47 %
Net Income Growth 29.7 % -18.16 % 5.07 %
Net Income 3 Yeari Growth Per Share 96.2 % -40.75 % 23.15 %
Net Income 5 Yeari Growth Per Share 99.06 % 49.13 % 116.76 %
Net Income 10 Yeari Growth Per Share 99.77 % 44.14 % 492.42 %
Operating Income Growth -28.04 % -1.8 % 2.84 %
Operating Cash Flow Growth (CFG) -120.52 % -6.64 % 2.48 %
Operating 3 Year CFG 91.07 % -21.78 % 27.03 %
Operating 5 Year CFG 97.68 % 65.54 % 111.28 %
Operating 10 Year CFG 99.31 % 70.94 % 378.1 %
EPS Growth 88.03 % -17.24 % 5.9 %
EPS Diluted Growth 88.03 % -17.08 % 6.06 %
Book Value Per Share -69.66 % -6.67 % 8.24 %
Share Holder 3 Year Equity Growth Per Share -92.83 % 7.23 % 138.87 %
Share Holder 5 Year Equity Growth Per Share 112.63 % 60.08 % 838.67 %
Share Holder 10 Year Equity Growth Per Share 102.65 % 103.57 % 1547.69 %
Dividend Per Share Growth - -5.75 % -
Dividend 3 Year Growth Per Share - 1.18 % -
Dividend 5 Year Growth Per Share - 42.62 % -
Dividend 10 Year Growth Per Share - 224 % -
Debt Growth -40.28 % -12.23 % -7.53 %
Free Cash Flow Growth -124.25 % -8.39 % 3.26 %
Updated On 30 Sep 2024 31 Dec 2024 31 Dec 2024
Profitability
APDN DHR-PB TMO DHR IDXX A
Gross Profit Margin TTM 39.58 % 61.37 % 39.81 % 61.37 % 61.72 % 52.96 %
Return on Assets TTM -373.49 % 4.38 % 6.38 % 4.38 % 30.34 % 9.98 %
Return on Equity TTM -374.62 % 6.88 % 13.11 % 6.88 % 67.78 % 19.97 %
Return on Capital Employed TTM -169.53 % 7.31 % 9.04 % 7.31 % 61.18 % 13.97 %
Net Income Per EBT TTM 286.16 % 83.9 % 92.29 % 83.9 % 80.67 % 87.52 %
EBT Per Ebit TTM 96.83 % 77.59 % 89.34 % 77.59 % 97.51 % 96.54 %
EBIT Per Revenue TTM -406.1 % 22.17 % 18.22 % 22.17 % 31.34 % 21.27 %
Cash Flow To Debt Ratio TTM -3760.86 % 37.48 % 21.44 % 37.48 % 424.21 % 43.85 %
Receivables Turnover TTM 16.57 6.46 4.91 6.46 7.35 4.91
Payables Turnover TTM 3.24 5.52 8.83 5.52 13.05 6.02
Inventory Turnover TTM 5.88 3.51 4.58 3.51 4.07 3.15
Fixed Asset Turnover TTM 389.96 % 451.41 % 429.75 % 451.41 % 563.59 % 345.27 %
Asset Turnover TTM 33.19 % 30.37 % 42.45 % 30.37 % 123.05 % 55.52 %
Operating Cash Flow Per Share TTM -21.99 8.89 20.24 8.89 13.58 5.25
Free Cash Flow Per Share TTM -23.18 7.06 16.17 7.06 11.91 4.92
Cash Per Share TTM 826.49 % 215 % 938.1 % 215 % 259.9 % 538.6 %
Operating Cash Flow Sales Ratio TTM -381.39 % 26.03 % 17.49 % 26.03 % 26.11 % 22.02 %
Free Cash Flow Operating Cash Flow Ratio TTM 105.44 % 79.41 % 79.87 % 79.41 % 87.64 % 93.78 %
Cash Flow Coverage Ratios TTM -3760.86 % 37.48 % 21.44 % 37.48 % 424.21 % 43.85 %
Price To Free Cash Flows Ratio TTM -0.22 30.57 34.37 30.71 60.59 28.99
Price To Operating Cash Flows Ratio TTM -0.26 24.08 27.48 24.19 53.16 27.33
Price Cash Flow Ratio TTM -0.26 24.08 27.48 24.19 53.16 27.33
Income Statement (TTM)
APDN DHR-PB TMO DHR IDXX A
Revenue $0B $23.88B $42.88B $23.88B $3.9B $6.51B
Gross Profit $0B $14.21B $17.73B $14.21B $2.38B $3.54B
Gross Profit Ratio 29.63% 59.5% 41.34% 59.5% 61.04% 54.3%
EBITDA $-0.01B $7.28B $11.8B $7.28B $1.28B $1.87B
Net Income $-0.01B $3.9B $6.34B $3.9B $0.89B $1.29B
EPS Diluted -1.82 5.29 16.53 5.29 10.67 4.43
Balance Sheet (MRQ)
APDN DHR-PB TMO DHR IDXX A
Long Term Debt $0B $16.47B $30.3B $16.47B $0.55B $3.49B
Total Liabilities $0B $27.99B $47.65B $27.99B $1.7B $5.95B
Total Equity $0.01B $49.55B $49.67B $49.55B $1.6B $5.9B
Total Investments $0B $1.82B $2.12B $1.82B $0.06B $0.18B
Total Debt $0B $17.15B $32.78B $17.15B $0.99B $3.57B
Total Assets $0.01B $77.54B $97.32B $77.54B $3.29B $11.85B
Cash Flow Statement (TTM)
APDN DHR-PB TMO DHR IDXX A
Net Income $-0.01B $3.9B $6.34B $3.9B $0.89B $1.29B
Inventory $-0B $0.15B $-0.03B $0.15B $-0.03B $0.03B
Dividends Paid $-0B $-0.77B $-0.58B $-0.77B $0B $-0.27B
Operating Cash Flow $-0.01B $6.69B $8.67B $6.69B $0.93B $1.75B
Capital Expenditure $-0B $-1.39B $-1.4B $-1.39B $-0.13B $-0.38B
Related Stocks
Ticker Name Price
A Agilent Technologies, Inc. 146.78
ACRS Aclaris Therapeutics, Inc. 2.255
ADVB Advanced Biomed Inc. Common Stock 0.4415
AKU Akumin Inc. 0.2887
AWH Aspira Women's Health Inc. 0.082
BDSX Biodesix, Inc. 8.57
BIAF bioAffinity Technologies, Inc. 2.195
BIAFW bioAffinity Technologies, Inc. 0.35
BIOC Biocept, Inc. 0.4349
BNBX Stader BNB 3.435
BNGO Bionano Genomics, Inc. 1.67
BNGOW BioNano Genomics, Inc. WT EXP 082123 0.0036
BNR Burning Rock Biotech Limited 11.79
CDNA CareDx, Inc 16.51
CEMI Chembio Diagnostics, Inc. 0.455
CHEK Check-Cap Ltd. 1.34
CNTG Centogene N.V. 0.325
CO Global Cord Blood Corporation 2.9876
CRL Charles River Laboratories International, Inc. 167.83
CSTL Castle Biosciences, Inc. 33.51
ETFs With Exposure to APDN
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 333.15
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 147.88
VXF Vanguard Extended Market Index Fund 0 209.18
VTSAX Vanguard Total Stock Market Index Fund 0 161.42
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 157.12
VITSX Vanguard Total Stock Market Index Fund 0 161.45
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 157.14
VEMPX Vanguard Extended Market Index InstlPlus 0 387.76
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 302.86
Unlock